Mouwasat Medical Services Company Stock price

Equities

4002

SA12C051UH11

Healthcare Facilities & Services

End-of-day quote Saudi Arabian S.E. 06:00:00 2024-02-20 pm EST 5-day change 1st Jan Change
126.2 SAR +1.28% Intraday chart for Mouwasat Medical Services Company +0.48% +12.88%
Sales 2023 * 2.66B 710M Sales 2024 * 3.03B 809M Capitalization 25.24B 6.73B
Net income 2023 * 670M 179M Net income 2024 * 770M 205M EV / Sales 2023 * 9.7 x
Net Debt 2023 * 574M 153M Net Debt 2024 * 376M 100M EV / Sales 2024 * 8.45 x
P/E ratio 2023 *
37.7 x
P/E ratio 2024 *
33 x
Employees 2,389
Yield 2023 *
1.68%
Yield 2024 *
1.92%
Free-Float 47.5%
More Fundamentals * Assessed data
Dynamic Chart
Mouwasat Medical Services Company Recommends Distribution of Cash Dividend for the Fiscal Year 2023 CI
Mouwasat Medical Services Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Mouwasat Medical Services Company Reports Earnings Results for the Second Quarter Ended June 30, 2023 CI
Mouwasat Medical Services Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Mouwasat Medical Services Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Mouwasat Medical Services Company Announces Executive Appointments CI
Mouwasat Medical Services Company Approves Appointment of Dr. Mohammed Hamad Alkathiri as Member of the Board of Directors and Audit Committee CI
Mouwasat Medical Services Co. Recommends the Distribution of Cash Dividend for Year 2022 CI
Mouwasat Medical Services Company Reports Earnings Results for the Third Quarter Ended September 30, 2022 CI
Mouwasat Medical Services Company completed the acquisition of Jeddah Doctors Company for SAR 102 million. CI
Mouwasat Medical Services Company Reports Earnings Results for the Second Quarter Ended June 30, 2022 CI
Mouwasat Medical Services Co. Announces Contract for the Construction of Mouwasat Hospital Project in Yanbu Industrial City CI
Mouwasat Medical Services Company signed a non-binding memorandum of understanding to acquire 100% of Al-Marasem international hospital. CI
Mouwasat Medical Services Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Mouwasat Medical Services Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 day+1.28%
1 week+0.48%
Current month+6.23%
1 month+4.30%
3 months+14.73%
6 months+16.64%
Current year+12.88%
More quotes
1 week
123.40
Extreme 123.4
128.40
1 month
116.80
Extreme 116.8
131.00
Current year
112.40
Extreme 112.4
131.00
1 year
90.00
Extreme 90
140.40
3 years
67.70
Extreme 67.7
140.40
5 years
34.15
Extreme 34.15
140.40
10 years
19.88
Extreme 19.875
140.40
More quotes
Managers TitleAgeSince
Chief Executive Officer - 06-01-23
Director of Finance/CFO - 17-01-03
Director/Board Member - 20-01-03
Members of the board TitleAgeSince
Chairman - 20-01-03
Chief Executive Officer - 06-01-23
Director/Board Member 56 20-01-03
More insiders
Date Price Change Volume
24-02-21 126.2 +1.28% 428,893
24-02-20 124.6 -1.11% 565,206
24-02-19 126 +1.45% 355,967
24-02-18 124.2 -1.11% 222,040
24-02-15 125.6 +1.13% 347,277

End-of-day quote Saudi Arabian S.E., February 20, 2024

More quotes
Mouwasat Medical Services Company is a Saudi Arabia-based company, which is engaged, through its multiple branches, in the acquisition, management, operation and maintenance of hospitals, medical centers, drug stores, pharmacies and wholesale of medical equipment and drugs. The Company operates in two segments: medical services segment, which includes Inpatient and outpatient services and pharmaceuticals segments. The Company also operates specialize centers, which include Long term care, rehabilitation center, stroke unit, cardiology center, nuclear medicine, fertility, skin care and badana clinic, among others. The Company operates approximately 9 branches and The Company’s subsidiaries includes Eastern Medical Services Company Limited and Jeddah Doctors Company.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
126.2 SAR
Average target price
119.3 SAR
Spread / Average Target
-5.46%
Consensus
  1. Stock
  2. Equities
  3. Stock Mouwasat Medical Services Company - Saudi Arabian S.E.
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer